Monarch eTNS, a Bioelectronic Medical Device for Pediatric ADHD, Now Available
The device gained FDA approval in 2019 based on data from a placebo-controlled clinical trial that included 62 children with moderate to severe ADHD.
Diagnosis & Disease Information
Pedmark Now Available to Reduce Risk of Cisplatin-Induced Hearing Loss in Children
Pedmark is the first FDA-approved therapy indicated to reduce the risk of cisplatin-induced hearing loss in children.
AAP: Children’s Body Mass Index Rose During Pandemic
Girls experienced more significant BMI increases than boys
Tool Helps ID Young Children at High Risk for Asthma
Authors say tool can be incorporated for routine screening in primary care settings
MPR Weekly Dose Podcast #134
Bivalent COVID-19 booster vaccines for children; wearable device to help treat fluid overload in adults with chronic heart failure; real-world data insights into molnupiravir efficacy; vaccine for the third trimester of pregnancy to prevent pertussis; and an FDA update on apomorphine infusion in Parkinson disease.
Bivalent COVID-19 Vaccines Authorized for Use as Boosters in Children
The bivalent Moderna and Pfizer-BioNTech COVID-19 Vaccines are authorized as a single booster dose at least 2 months after the primary or booster vaccination.
Aflibercept Granted Priority Review for Retinopathy of Prematurity
The sBLA is supported by data from the phase 3 FIREFLEYE and BUTTERFLEYE trials that evaluated the efficacy and safety aflibercept in infants with ROP.
Early Steroid Use Does Not Cut Hospital Stay for Non-MIS-C COVID-19
Early use of steroids in children hospitalized for COVID-19 without MIS-C not associated with shorter length of stay
Boostrix Approved for Use During Pregnancy to Prevent Pertussis in Infants
Effectiveness in preventing pertussis among infants younger than 2 months of age when administered during the third trimester of pregnancy was based on a reanalysis of data from an observational case-control study.
